Chargement en cours...
MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
Women living with androgenic PCOS (WLWP) experience unpredictable oligomenorrhea(1) and are at increased risk for endometrial cancer(2). Oral micronized progesterone (OMP) given cyclically (14 days/cycle or 4 weeks, Cyclic OMP), in luteal phase doses(3) (300 mg at bedtime) as a “luteal phase replace...
Enregistré dans:
| Publié dans: | J Endocr Soc |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7209032/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2339 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|